ADA Scientific Sessions Recap—Day #4: Simi Ahmed, Ph.D.

in ,

The American Diabetes Association’s Scientific Sessions is almost coming to a close! Here is Simi Ahmed, Ph.D., head of the immunotherapy program at JDRF, who highlights some of the important immune-based therapies and what they mean for the type 1 diabetes community:

By Alexandra Mulvey